The Treatment of Cardiovascular Disease Continuum: Focus on Pharmacologic Management and RAS Blockade

E-ISSN： 2212-3938|5|2|89-95

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.2, 2010-05, pp. : 89-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational pharmacologic treatment for liver disease

By Siatkosky Lori L Shermock Kenneth M Younossi Zobair M

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1281-1293

Informa Healthcare

Access to resources Recommend Favorite

Pharmacologic Management of Arrhythmias in Patients with Congenital Heart Disease

By Batra A.S. Luna C.F. Silka M.J.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 91-103

Adis International

Access to resources Recommend Favorite

Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum

Current Pharmaceutical Design, Vol. 14, Iss. 24, 2008-08 ,pp. : 2445-2461

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Management for the Prevention of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Torcetrapib: promising in the treatment of cardiovascular disease

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite